
Two top-selling antidepressants have had their safety records challenges, after the FDA asked Pfizer to change the labelling of its …

GlaxoSmithKline has decided not to sell off several of its ageing brands in the face of continuing business problems. The …

Health Canada has told GlaxoSmithKline that it wants to see the firm fix major problems at the country’s only flu …

GlaxoSmithKline is looking to make more than £7 billion by selling off its ageing portfolio of established drugs. This is …

GlaxoSmithKline’s manufacturing woes are getting worse after the firm was hit with a second FDA warning in as many days. …
GlaxoSmithKline will pay $3 billion in fraud charges, the largest of its kind in US history. The charges relate to …

GlaxoSmithKline has responded to an edition of US current affairs show 60 Minutes centring on manufacturing problems at its now-closed …